par 164 (Benztropine 0.5 mg)

Pill imprint par 164 has been identified as Benztropine mesylate 0.5 mg.

Benztropine is used in the treatment of extrapyramidal reaction; parkinson's disease; hyperhidrosis and belongs to the drug class anticholinergic antiparkinson agents. FDA has not classified the drug for risk during pregnancy. Benztropine 0.5 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for par 164 (Benztropine 0.5 mg)

Benztropine mesylate 0.5 mg par 164  Front
Benztropine mesylate 0.5 mg par 164  Back
Benztropine mesylate 0.5 mg par 164
Benztropine mesylate
par 164
0.5 mg
6.00 mm
Prescription only
Drug Class:
Anticholinergic antiparkinson agents
Pregnancy Category:
N - Not classified
CSA Schedule:
N - Not a controlled drug
Par Pharmaceutical Inc.
National Drug Code (NDC):
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
00182-1299 Goldline Laboratories Inc
00904-1055 Major Pharmaceuticals
63739-0033 McKesson Packaging Services
68115-0826 Dispensexpress Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Learn how medication, diet, and exercise are key to managing Multiple Sclerosis. Click Here